The audit has apparently taken about 10 years longer than expected, no?

Is there some point at which we should all just confront Eric on his BS? Or do you think it is for the best to just continue as if the decade of missed deadlines was all just some random sequence of events that

Even if you read it as needing another trial which is obv up for debate (also would be for FDA - EMA clearly not), it would still mean Anavex have better and more robust long term trial data (3-4 years) compared to any AD phase 2 previously done by a company.
Eli Lily jumped $15.3 billion (

Company alluded to a Phase 4.

"A phase 4 clinical trial, also known as a post-marketing surveillance trial, is a study that examines a drug's safety and effectiveness after it has been approved and is available for patients."

Key is that this is a study used afte

$MITQ @ 70s: ..Volume elevating....Last of the AI microfloats yet to rip.

$NIO Book Value Per Share (mrq) $12.43 Total Cash (mrq) $36.27B

That is why you are underwater on Spooz because you believe anything Spooz posts on X as true and factual. LOLOL!

Spooz
@SpoozInc
2h
$SPZI The increase in the Authorized Shares is to secure potential acquisitions and to support the culmination of the commodity and

$MITQ @ 70s: ..Volume elevating....Last of the AI microfloats yet to rip.

You haven't stopped anything and you never will
I'm not trying to stop anything. Unlike you and your lying pumps that helps and furthers this scam, I'm simply warning people here with documentation that this is a scam and that Jake P. Noch has a history of perpetrating huge frauds - including

VRME for the win today!

emPath ....thinking nvidia now hiring asic engineers in taiwan. i wonder why china wants more influence in taiwan? asics and fpga; asics and memristors, which remembering em state can go to tha switching /gate position..with soft fabric and software stacks and api's with the emPath information....

If I were a betting person, I would bet that mRESVIA and DCVax-L will be among the drugs that are approved by MHRA in January.


Who's going tell him he's about to be wrong? Maybe, try February, March, April and so on. 😝

Trying wash trading to look like interest again? Lots of beneficial ownership shenanigans as usual. Tax write offs anyone?

I doubt same "Person". Buys are making MM's buy their shorts back
Did good slap an ask they'll lose their shorts and show their A$$
JMO.

The ability of Anavex snatching defeat from the claws of victory is uncanny!

Spot on. We have used a few bullets already and going nowhere. If we do get bought out it will be for far less than any of us expected.

I now have the largest position in Pays that I have held in years. Looking forward to large gains in the next year or two on this one.

If you are depending on that it's ashame . You are in the wrong business.

Jeff if you recall, there was a promo…….

group that talked about the OS reduction through a Preferred offering about 2 years ago. It was when the pps ran up to around half a penny.

Then they dumped and stopped pumping.

But they mentioned it in a podcast

You asked...

How many trolls like Slinger spend their days obsessively spreading cherry-picked, manipulated nonsense, ignoring facts, and attacking progress just to get a rise out of others? Unfortunately, the answer to that is: far too many.

🤣🤣🤣

I’m sure he’s still there Loc. Why would he leave – he’s still getting paid? The bigger question is, has he done enough to satisfy his six-month incentive metrics. If so, we should get an 8-K announcing that 500K more shares were granted via meeting these metrics. So, no communication forthcoming co

https://ih.advfn.com/stock-market/NASDAQ/sana-biotechnology-SANA/stock-news/95237254/form-8-k-current-report

Averaged down for a rainy day!

Eat those freakin awesome 5s up newbies. They are so cheap for a quality company that has so much on the horizon and about to explode any time now.

https://www.yahoo.com/news/maga-republican-slammed-saying-california-003138819.html

Once again, Republicans from California, let's not pay for anything.